Aytekin Akyol

About Aytekin Akyol

Aytekin Akyol, With an exceptional h-index of 16 and a recent h-index of 13 (since 2020), a distinguished researcher at Hacettepe Üniversitesi, specializes in the field of Cancer, transgenic animal models, gastrointestinal pathology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Abstract PO4-23-10: Restoring the efficacy of standard of care in treatment-refractory ER+ breast cancer by re-activation of cAMP-ROS-DNA damage axis

Targeting PDE4D reinstates toxic PARP trapping via cAMP-ROS-DNA damage axis and restores the efficacy of standard of care in treatment-refractory ER+ breast cancer

The Impact of Dose Rate on the Tumor Microenvironment Using Flattening-filter-free Beams

Lysosomal alkalinization in nutrient restricted cancer cells activates cytoskeletal rearrangement to enhance partial epithelial to mesenchymal transition

The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma

Abstract A008: Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

The role of PEDF, VEGF, and Ki-67 in tissue invasion and tumor angiogenesis of medullary thyroid carcinoma

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

Aytekin Akyol Information

University

Position

Profesor of Pathology

Citations(all)

1468

Citations(since 2020)

682

Cited By

993

hIndex(all)

16

hIndex(since 2020)

13

i10Index(all)

18

i10Index(since 2020)

15

Email

University Profile Page

Google Scholar

Aytekin Akyol Skills & Research Interests

Cancer

transgenic animal models

gastrointestinal pathology

Top articles of Aytekin Akyol

Abstract PO4-23-10: Restoring the efficacy of standard of care in treatment-refractory ER+ breast cancer by re-activation of cAMP-ROS-DNA damage axis

Cancer Research

2024/5/2

Targeting PDE4D reinstates toxic PARP trapping via cAMP-ROS-DNA damage axis and restores the efficacy of standard of care in treatment-refractory ER+ breast cancer

Cancer Research

2024/3/22

The Impact of Dose Rate on the Tumor Microenvironment Using Flattening-filter-free Beams

Clinical Oncology

2024/3/18

Lysosomal alkalinization in nutrient restricted cancer cells activates cytoskeletal rearrangement to enhance partial epithelial to mesenchymal transition

Translational Oncology

2024/3/1

Aytekin Akyol
Aytekin Akyol

H-Index: 10

The prognostic and predictive role of class III β-Tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma

Pancreatology

2024/1/20

Abstract A008: Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

Cancer Research

2024/1/9

The role of PEDF, VEGF, and Ki-67 in tissue invasion and tumor angiogenesis of medullary thyroid carcinoma

Acta Medica

2024

Olcay Kurtulan
Olcay Kurtulan

H-Index: 2

Aytekin Akyol
Aytekin Akyol

H-Index: 10

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer

Nature Communications

2023/11/2

1638P The prognostic and predictive role of class III β-tubulin and hENT1 expression in patients with advanced pancreatic ductal adenocarcinoma

Annals of Oncology

2023/10/1

The Effect of Dose Rate on Tumor Microenvironment in External Beam Radiotherapy

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Rewiring of endolysosomal signaling with nutrient depletion in cancer cells

2023/9/13

Aytekin Akyol
Aytekin Akyol

H-Index: 10

Nalan Liv
Nalan Liv

H-Index: 14

Prognostic and predictive value of tumor infiltrating lymphocytes in combination with systemic inflammatory markers in colon cancer

Clinics and Research in Hepatology and Gastroenterology

2023/8/1

Brain-Derived Neurotrophic Factor: Its Role in Energy Balance and Cancer Cachexia

2023/7/18

Barış Çerçi
Barış Çerçi

H-Index: 5

Aytekin Akyol
Aytekin Akyol

H-Index: 10

Characterization of the Subcellular Distribution of Phospho-β-catenin in Colorectal Cancer

in vivo

2023/7/1

Gunes Guner
Gunes Guner

H-Index: 12

Aytekin Akyol
Aytekin Akyol

H-Index: 10

Role of reduced Bdnf expression in novel Apc mutant allele-induced intestinal and colonic tumorigenesis in mice

in vivo

2023/7/1

Gunes Guner
Gunes Guner

H-Index: 12

Aytekin Akyol
Aytekin Akyol

H-Index: 10

PO-2214 Dose Rate in External Beam Radiotherapy: Missing Piece of the Puzzle?

Radiotherapy and Oncology

2023/5/1

Overcoming tamoxifen resistance by re-activating cAMP-Ca2+−ROS-ferroptosis axis in ER+ breast cancer

Cancer Research

2023/4/4

Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer

Clinics and Research in Hepatology and Gastroenterology

2023/3/1

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer

bioRxiv

2023

A novel gene list identifies tumors with a stromal-mesenchymal phenotype and worse prognosis in gastric cancer

2023

Aytekin Akyol
Aytekin Akyol

H-Index: 10

See List of Professors in Aytekin Akyol University(Hacettepe Üniversitesi)

Co-Authors

academic-engine